These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 22421508)
1. B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Asanin M; Stankovic S; Mrdovic I; Matic D; Savic L; Majkic-Singh N; Ostojic M; Vasiljevic Z Peptides; 2012 May; 35(1):74-7. PubMed ID: 22421508 [TBL] [Abstract][Full Text] [Related]
2. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385 [TBL] [Abstract][Full Text] [Related]
3. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Stankovic S; Asanin M; Majkic-Singh N; Ignjatovic S; Mihailovic M; Nikolajevic I; Mrdovic I; Matic D; Savic L; Marinkovic J; Ostojic M; Vasiljevic Z Clin Lab; 2012; 58(1-2):125-31. PubMed ID: 22372355 [TBL] [Abstract][Full Text] [Related]
4. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
5. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Grabowski M; Filipiak KJ; Karpinski G; Wretowski D; Rdzanek A; Huczek Z; Horszczaruk GJ; Kochman J; Rudowski R; Opolski G Am Heart J; 2004 Oct; 148(4):655-62. PubMed ID: 15459597 [TBL] [Abstract][Full Text] [Related]
6. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415 [TBL] [Abstract][Full Text] [Related]
7. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction. Jeong YH; Kim WJ; Park DW; Choi BR; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Park SW; Park SJ Int J Cardiol; 2010 May; 141(2):175-81. PubMed ID: 19144424 [TBL] [Abstract][Full Text] [Related]
8. In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction. Oduncu V; Erkol A; Tanalp AC; Dündar C; Tanboğa IH; Sırma D; Karagöz A; Karabay CY; Izgi A; Pala S; Tigen K; Kırma C Turk Kardiyol Dern Ars; 2011 Oct; 39(7):540-8. PubMed ID: 21983763 [TBL] [Abstract][Full Text] [Related]
9. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651 [TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ; Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115 [TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide levels as a predictor for new atrial fibrillation during hospitalization in patients with acute ischemic stroke. Shibazaki K; Kimura K; Fujii S; Sakai K; Iguchi Y Am J Cardiol; 2012 May; 109(9):1303-7. PubMed ID: 22341921 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153 [TBL] [Abstract][Full Text] [Related]
15. Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study. Kurt IH; Demirkol S; Ünal I; Batur MK Anadolu Kardiyol Derg; 2012 Mar; 12(2):107-14. PubMed ID: 22281789 [TBL] [Abstract][Full Text] [Related]
16. [Effect of primary percutaneous coronary intervention on plasma B-type natriuretic peptide in patients with acute myocardial infarction]. Liang JQ; Zhou XX; Huang YG; Zhang GX Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1555-7. PubMed ID: 16361163 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty. Katayama T; Nakashima H; Yonekura T; Honda Y; Suzuki S; Yano K J Cardiol; 2003 Nov; 42(5):195-200. PubMed ID: 14658407 [TBL] [Abstract][Full Text] [Related]
18. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182 [TBL] [Abstract][Full Text] [Related]
19. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction. Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611 [TBL] [Abstract][Full Text] [Related]
20. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]